Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma

Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma

Item
http://www.wikidata.org/entity/Q28285447
Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinomaA matrix metalloproteinase mediates long-distance attenuation of stem cell proliferation.Glypican-1 regulates anaphase promoting complex/cyclosome substrates and cell cycle progression in endothelial cells.Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model.Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liverMicroRNA-1291-mediated silencing of IRE1α enhances Glypican-3 expression.Fine-tuning of cell signaling by glypicans.Endoplasmic reticulum quality control in cancer: Friend or foe.Impaired autophagy response in human hepatocellular carcinoma.The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.The Potential of N-Rich Plasma-Polymerized Ethylene (PPE:N) Films for Regulating the Phenotype of the Nucleus Pulposus.Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.Review of X-linked syndromes with arthrogryposis or early contractures-aid to diagnosis and pathway identification.Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.
P2860

Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma

Item
http://www.wikidata.org/entity/Q28285447
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@ast
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@en
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@nl
type
label
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@ast
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@en
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@nl
prefLabel
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@ast
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@en
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P577
P698
P3181
P356
P1433
P1476
Glypican-3: from the mutations ...... r for hepatocellular carcinoma
@en
P2093
P304
P31
P3181
P356
10.1016/J.YEXMP.2006.10.010
P407
P433
P478
P577
P698